Tuberculosis of (inner) (middle) ear
ICD-10 A18.6 is a billable code used to indicate a diagnosis of tuberculosis of (inner) (middle) ear.
Tuberculosis of the ear, specifically affecting the inner or middle ear, is a rare but serious manifestation of extrapulmonary tuberculosis. It typically occurs in individuals with a history of pulmonary tuberculosis or those with compromised immune systems. The condition can present with symptoms such as ear pain, hearing loss, and discharge from the ear. Diagnosis is often made through a combination of clinical evaluation, imaging studies such as CT scans, and microbiological tests including sputum tests and culture of ear discharge. Treatment usually involves a prolonged course of antitubercular medications, and monitoring for drug resistance is critical due to the potential for multidrug-resistant tuberculosis (MDR-TB). Public health implications are significant, as tuberculosis is a communicable disease, necessitating contact tracing and isolation procedures for active cases. Early diagnosis and treatment are essential to prevent complications and transmission.
Detailed clinical notes on ear examination findings, imaging results, and treatment plans.
Patients presenting with ear pain and hearing loss, especially in those with a history of tuberculosis.
Need for collaboration with infectious disease specialists for comprehensive management.
Thorough documentation of tuberculosis history, treatment regimens, and monitoring for drug resistance.
Management of patients with extrapulmonary tuberculosis and monitoring for complications.
Awareness of public health reporting requirements and contact tracing.
When ear cleaning is necessary before further evaluation.
Document the reason for cerumen removal and any findings.
Otolaryngologists should ensure thorough documentation of ear examination.
Common symptoms include ear pain, hearing loss, and discharge from the ear. Patients may also experience systemic symptoms such as fever and malaise.
Diagnosis typically involves clinical evaluation, imaging studies, and microbiological tests such as sputum cultures or ear discharge cultures.
Treatment usually consists of a multi-drug regimen of antitubercular medications, and monitoring for drug resistance is essential.
Public health measures include contact tracing, isolation of active cases, and education on tuberculosis transmission.
